Usted se encuentra revisando un registro bibliográfico de la BDU Para conocer mas sobre la Base de Datos Unificada haga click en el ícono del home

Titulos:
WHO Expert Committee on Biological Standardization fifty-second report.
Idiomas:
eng
ISBN:
1-280-09743-4; 9786610097432; 92-4-068152-3
Lugar de Edición:
Geneva :
Editor:
World Health Organization,
Fecha de Edición:
2004.
Notas #:
"The WHO Expert Committee on Biological Standardization met in Geneva from 26 to 30 November 2001"--Introd.
Notas Formateada:
505 0 Introduction -- General. Developments in biological standardization. Bioterrorism. International nonproprietary names for biotechnology-derived medicinal products -- International guidelines, recommendations, and other matters related to the manufacture and quality control of biologicals. Guidelines on clinical evaluation of vaccines: regulatory expectations. Group C meningococcal conjugate vaccines. Inactivated oral cholera vaccines. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products. Pneumococcal conjugate vaccines. Potency assays for diphtheria and tetanus vaccines. Pertussis vaccines. Preventive human immunodeficiency virus vaccines. Cell substrate safety. Cell banks. Yellow fever. Poliomyelitis vaccine, oral. Transmissible spongiform encephalitis and the safety of biologicals. Antivenoms. Gene therapy. Discontinuation requirements -- International reference materials. Biological substances: international standards and reference reagents. International biological standards for in vitro diagnostic procedures. International reference materials for the diagnosis and study of transmissible spongiform encephalitis -- Antibodies. Human antibody against human platelet antigen 5b -- Blood products and related substances. International reference panels for the validation of serological and nucleic acid based test for the detection of hepatitis B, hepatitis C and human immunodeficiency virus in blood screening. Factors II, VII, X, plasma. Von Willebrand factor. Streptokinase. Unfractioned heparin and low-molecular-weight heparin -- Cytokines, growth factors and endocrinological substances. Human chorionic gonadotrophin. Ciliary neurotrophic factor. Prolactin and its glycosylated and non-glycosylated components -- Miscellaneous. Pertussis toxin standard -- Annex 1. Guidelines on clinical evaluation of vaccines: regulatory expectations -- Annex 2. Recommendations for the production and control of meningococcal group C conjugate vaccines -- Annex 3. Guidelines for the production and control of inactivated oral cholera vaccines -- Annex 4. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood products -- Annex 5. Biological substances: international standards and reference reagents -- Annex 6. Recommendations and guidelines for biological substances used in medicine and other documents.
Palabras clave:
Biological products; Drugs

Leader:
nam
Campo 008:
050120s2004 sz a ob i100 0 eng d
Campo 020:
^a1-280-09743-4
Campo 020:
^a9786610097432
Campo 020:
^a92-4-068152-3
Campo 035:
^a(CKB)1000000000033189
Campo 035:
^a(OCoLC)559332398
Campo 035:
^a(CaPaEBR)ebrary10075419
Campo 035:
^a(SSID)ssj0000285551
Campo 035:
^a(PQKBManifestationID)11273316
Campo 035:
^a(PQKBTitleCode)TC0000285551
Campo 035:
^a(PQKBWorkID)10277457
Campo 035:
^a(PQKB)10203966
Campo 035:
^a(MiAaPQ)EBC284745
Campo 035:
^a(EXLCZ)991000000000033189
Campo 040:
^aMiAaPQ^cMiAaPQ^dMiAaPQ
Campo 041:
^aeng
Campo 110:
2 ^aWHO Expert Committee on Biological Standardization.^bMeeting^n(52nd :^d2001 :^cGeneva, Switzerland)
Campo 245:
10^aWHO Expert Committee on Biological Standardization^h[electronic resource] :^bfifty-second report.
Campo 246:
Campo 260:
^aGeneva :^bWorld Health Organization,^c2004.
Campo 300:
^a1 online resource (244 p.)
Campo 490:
1 ^aWHO technical report series,^x0512-3054 ;^v924
Campo 500:
^a"The WHO Expert Committee on Biological Standardization met in Geneva from 26 to 30 November 2001"--Introd.
Campo 505:
0 ^a505 0 Introduction -- General. Developments in biological standardization. Bioterrorism. International nonproprietary names for biotechnology-derived medicinal products -- International guidelines, recommendations, and other matters related to the manufacture and quality control of biologicals. Guidelines on clinical evaluation of vaccines: regulatory expectations. Group C meningococcal conjugate vaccines. Inactivated oral cholera vaccines. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products. Pneumococcal conjugate vaccines. Potency assays for diphtheria and tetanus vaccines. Pertussis vaccines. Preventive human immunodeficiency virus vaccines. Cell substrate safety. Cell banks. Yellow fever. Poliomyelitis vaccine, oral. Transmissible spongiform encephalitis and the safety of biologicals. Antivenoms. Gene therapy. Discontinuation requirements -- International reference materials. Biological substances: international standards and reference reagents. International biological standards for in vitro diagnostic procedures. International reference materials for the diagnosis and study of transmissible spongiform encephalitis -- Antibodies. Human antibody against human platelet antigen 5b -- Blood products and related substances. International reference panels for the validation of serological and nucleic acid based test for the detection of hepatitis B, hepatitis C and human immunodeficiency virus in blood screening. Factors II, VII, X, plasma. Von Willebrand factor. Streptokinase. Unfractioned heparin and low-molecular-weight heparin -- Cytokines, growth factors and endocrinological substances. Human chorionic gonadotrophin. Ciliary neurotrophic factor. Prolactin and its glycosylated and non-glycosylated components -- Miscellaneous. Pertussis toxin standard -- Annex 1. Guidelines on clinical evaluation of vaccines: regulatory expectations -- Annex 2. Recommendations for the production and control of meningococcal group C conjugate vaccines -- Annex 3. Guidelines for the production and control of inactivated oral cholera vaccines -- Annex 4. Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood products -- Annex 5. Biological substances: international standards and reference reagents -- Annex 6. Recommendations and guidelines for biological substances used in medicine and other documents.
Campo 650:
0^aBiological products^xStandards^vCongresses.
Campo 650:
0^aDrugs^xStandards^vCongresses.
Proveniencia:
^aUniversidad de San Andrés - Biblioteca Max Von Buch
Seleccionar y guardar el registro Haga click en el botón del carrito
Institucion:
Universidad de San Andrés
Dependencia:
Biblioteca Max Von Buch

Compartir este registro en Redes Sociales

Seleccionar y guardar el registro Haga click en el botón del carrito